© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
November 05, 2020
Learn about the results of the recent study on deutetrabenazine and the ways it is helping patients with tardive dyskinesia.
May 31, 2019
There are a few things that we all agree on, as reflected in a recent consensus statement.
May 30, 2019
Numbers don’t tell the whole story, but gaining a better sense of the frequency, risks, and impact on patients’ quality of life can help improve treatment efforts and enhance outcomes.
May 22, 2019
There are ways to prevent, manage, and treat TD, and this podcast will guide you through those steps from FDA-approved medications to off-label therapies.
May 13, 2019
Once thought untreatable, we now have two FDA-approved medications for TD and a handful of off-label options. More in this research update.
Tardive dyskinesia hits affected populations hard, especially older folks with poor support systems.
April 23, 2019
Recent studies and reviews report great progress in bringing TD under control.
April 17, 2019
Some dyskinesias improve with antipsychotic treatment, and these types are more common than thought. More in this podcast.
A prediction model may help identify treatment characteristics associated with TD among patients with psychiatric disorders taking antipsychotic medications.
April 01, 2019
This video will help clinicians detect tardive dyskinesia and movement disorders in patients taking antipsychotic drugs.